Skip to content

Less Than 60% of US Pharmacies Stock Buprenorphine for SUD, Creating Multiple Treatment Deserts

By | June 12, 2023 |

Only 57.9% of pharmacies in the U.S. stock buprenorphine, a prescription used for medication-assisted treatment (MAT).

That’s according to new research published in JAMA highlighting a potential access issue for patients in substance use disorder (SUD) treatment. The cross-sectional study was based on data from virtual MAT provider Bicycle Health and included responses from 5,283 unique pharmacies across 32 states about their supply of buprenorphine.

 

- Read more...